RSV-IN-1

• CAT Number: I019818
• CAS Number: 861139-16-4
• Molecular Formula: C₂₀H₂₁N₅O₄S
• Molecular Weight: 427.48
• Purity: ≥95%
• Target: RSV
• Storage: Store at -20°C
• IUPAC Name: N-(2-hydroxyethyl)-4-methoxy-N-methyl-3-(6-methyl-[1,2,4]triazolo[3,4-a]phthalazin-3-yl)benzenesulfonamide
• InChI: InChI=1S/C20H21N5O4S/c1-13-15-6-4-5-7-16(15)19-21-22-20(25(19)23-13)17-12-14(8-9-18(17)29-3)30(27,28)24(2)10-11-26/h4-9,12,26H,10-11H2,1-3H3
• InChIKey: RKHSOIYWKCMPHF-UHFFFAOYSA-N
• SMILES: CC1=NN2C(=NN=C2C3=C(C=CC(=C3)S(=O)(=O)N(C)CCO)OC)C4=CC=CC=C14

RSV-IN-1（Cat No.:I019818）is a potent, selective inhibitor of Respiratory Syncytial Virus (RSV) replication. It acts by targeting the RSV fusion (F) protein, preventing the virus from entering host cells and inhibiting viral replication. RSV-IN-1 has shown promise in preclinical studies for treating RSV infections, particularly in vulnerable populations such as infants, the elderly, and immunocompromised individuals. Its mechanism of action offers a potential therapeutic option for managing RSV-related respiratory illnesses, reducing disease severity, and preventing viral transmission in clinical settings.

Reference

[1]. Lundin A, et al. Two novel fusion inhibitors of human respiratory syncytial virus. Antiviral Res. 2010 Dec;88(3):317-24.